Indivior’s Shaun Thaxter to present at the Jefferies London Healthcare Conference on November 15th

| 11/15/2017 |

Slough, UK, and Richmond, VA, 6 November 2017 – Indivior PLC (LON: INDV) today announced that Shaun Thaxter, CEO, will present at the Jefferies London Healthcare Conference on November 15th, 2017, at 9:20 a.m. local time, in London. Mark Crossley, CFO, and Jason Thompson, VP of Investor Relations, will also be in attendance. Thaxter will review Indivior’s business and outlook. The presentation will be webcast live, and the broadcast and presentation materials will be available on the “Investors” section of Indivior’s website (www.indivior.com) on November 15th, 2017. Click here to access the live webcast.

About Indivior

Indivior is a global specialty pharmaceutical company with a 20-year legacy of leadership in patient advocacy and health policy while providing education on evidence-based treatment models that have revolutionized modern addiction treatment. The name is the fusion of the words individual and endeavour, and the tagline “Focus on you” makes the Company’s commitment clear. Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of opioid dependence treatments, Indivior has a strong pipeline of product candidates designed to both expand on its heritage in this category and address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder and schizophrenia. Headquartered in the United States in Richmond, VA, Indivior employs more than 900 individuals globally and its portfolio of products is available in over 40 countries worldwide. Visit www.indivior.com to learn more.


Contact:

Jason Thompson, Indivior
Vice President, Investor Relations
+1 804-423-8916
Jason.thompson@indivior.com